Explore
Validate
Learn60626-1-Ig
antibody from Proteintech Group
Targeting: CDKN2A
ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60626-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- P16-INK4A antibody
- Antibody type
- Monoclonal
- Description
- P16-INK4A antibody (Catalog no. 60626-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: WB, IHC, IF/ICC, ELISA
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1C9D3
Submitted references The anti-aging drug Senolytics alleviates vascular endothelial cell senescence by antagonizing the JPX-BRD4-p65 complex.
Aging-induced decrease in progenitor B cells enhances the osteoclastogenesis of bone marrow macrophages via ROS-activated Fos/CCL3 signaling‌ pathway.
Development and In vitro antitumor evaluation of a novel anti-p16 antibody fragment-drug conjugate.
Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.
Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction.
Mao K, Zhu W, Sun H, Zheng H, Fu Z
Cellular signalling 2026 Mar;139:112342
Cellular signalling 2026 Mar;139:112342
Aging-induced decrease in progenitor B cells enhances the osteoclastogenesis of bone marrow macrophages via ROS-activated Fos/CCL3 signaling‌ pathway.
Sun R, Luo L, Chen Y, Sun L, Huo Y, Ding C, Wang Y
Immunity & ageing : I & A 2026 Feb 10;23(1)
Immunity & ageing : I & A 2026 Feb 10;23(1)
Development and In vitro antitumor evaluation of a novel anti-p16 antibody fragment-drug conjugate.
He H, Chen X, Chen Y, Li Q, Yang F, Zhou L
International immunopharmacology 2026 Apr 1;174:116359
International immunopharmacology 2026 Apr 1;174:116359
Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer.
Cheng Y, Liu B, Xin J, Wu X, Li W, Shang J, Wu J, Zhang Z, Xu B, Du M, Cheng G, Wang M
Nature aging 2025 May;5(5):909-928
Nature aging 2025 May;5(5):909-928
Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction.
Zhang K, Yin Q, Ma Y, Cao M, Li L, Jin X, Leng J
Human vaccines & immunotherapeutics 2025 Dec;21(1):2479229
Human vaccines & immunotherapeutics 2025 Dec;21(1):2479229
No comments: Submit comment
No validations: Submit validation data